Parametric Portfolio Associates LLC increased its stake in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 15.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,026 shares of the medical device company’s stock after purchasing an additional 8,386 shares during the quarter. Parametric Portfolio Associates LLC owned approximately 0.13% of Cooper Companies, Inc. (The) worth $15,090,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in COO. BlackRock Inc. increased its position in Cooper Companies, Inc. (The) by 2,849.1% during the 1st quarter. BlackRock Inc. now owns 3,071,637 shares of the medical device company’s stock worth $613,991,000 after purchasing an additional 2,967,481 shares in the last quarter. Pioneer Investment Management Inc. increased its position in Cooper Companies, Inc. (The) by 136.6% during the 2nd quarter. Pioneer Investment Management Inc. now owns 1,226,250 shares of the medical device company’s stock worth $293,589,000 after purchasing an additional 708,028 shares in the last quarter. Janus Capital Management LLC increased its position in Cooper Companies, Inc. (The) by 35.7% during the 1st quarter. Janus Capital Management LLC now owns 1,743,182 shares of the medical device company’s stock worth $348,441,000 after purchasing an additional 458,173 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. acquired a new position in Cooper Companies, Inc. (The) during the 2nd quarter worth approximately $71,050,000. Finally, William Blair Investment Management LLC acquired a new position in Cooper Companies, Inc. (The) during the 2nd quarter worth approximately $65,037,000. Institutional investors and hedge funds own 95.79% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/10/08/cooper-companies-inc-the-coo-shares-bought-by-parametric-portfolio-associates-llc.html.

In other news, CEO Paul L. Remmell sold 9,294 shares of the business’s stock in a transaction that occurred on Friday, July 14th. The shares were sold at an average price of $248.46, for a total value of $2,309,187.24. Following the completion of the sale, the chief executive officer now directly owns 6,186 shares in the company, valued at approximately $1,536,973.56. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Randal Golden sold 1,621 shares of the business’s stock in a transaction that occurred on Tuesday, July 11th. The stock was sold at an average price of $243.65, for a total transaction of $394,956.65. Following the completion of the sale, the vice president now owns 1,731 shares of the company’s stock, valued at $421,758.15. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 14,892 shares of company stock valued at $3,678,270. Company insiders own 1.60% of the company’s stock.

A number of research firms recently issued reports on COO. Jefferies Group LLC set a $250.00 price objective on shares of Cooper Companies, Inc. (The) and gave the stock a “buy” rating in a research report on Thursday, August 17th. Cleveland Research reiterated a “buy” rating on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, August 22nd. Zacks Investment Research cut shares of Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research report on Monday, August 14th. BidaskClub cut shares of Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research report on Friday, August 4th. Finally, Robert W. Baird reiterated a “buy” rating and set a $251.00 price objective on shares of Cooper Companies, Inc. (The) in a research report on Thursday, August 24th. Seven analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $261.67.

Cooper Companies, Inc. (NYSE:COO) opened at 241.33 on Friday. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39. The firm has a market capitalization of $11.81 billion, a PE ratio of 34.61 and a beta of 0.54. The firm has a 50-day moving average of $242.99 and a 200 day moving average of $229.18.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.58 by $0.06. The firm had revenue of $556.00 million during the quarter, compared to analyst estimates of $552.32 million. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The business’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.30 EPS. Equities research analysts forecast that Cooper Companies, Inc. will post $9.73 earnings per share for the current year.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.